M
Matthias Favreau
Researcher at Ludwig Maximilian University of Munich
Publications - 10
Citations - 101
Matthias Favreau is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Medicine & Eating disorders. The author has an hindex of 2, co-authored 6 publications receiving 34 citations.
Papers
More filters
Journal ArticleDOI
Bulimia nervosa in times of the COVID-19 pandemic-Results from an online survey of former inpatients.
TL;DR: In challenging times when face‐to‐face therapy options are restricted, e‐health treatments such as videoconferencing therapy should be considered to ensure continuity of care.
Journal ArticleDOI
Psychological consequences and differential impact of the COVID-19 pandemic in patients with mental disorders.
Matthias Favreau,Andreas Hillert,Bernhard Osen,Thomas Gärtner,Sandra Hunatschek,Moritz Riese,Karina Hewera,Ulrich Voderholzer +7 more
TL;DR: In this article, the authors evaluated the impact of the COVID-19 pandemic on patients with various psychiatric disorders who were admitted to inpatient treatment and found that patients with anxiety disorders were less affected by contact restrictions compared with eating disorders and depression.
Journal ArticleDOI
Impact of comorbid borderline personality disorder on the outcome of inpatient treatment for anorexia nervosa: a retrospective chart review.
Ulrich Voderholzer,Ulrich Voderholzer,Matthias Favreau,Sandra Schlegl,Johannes Baltasar Hessler-Kaufmann +4 more
TL;DR: In this paper, the authors investigated whether patients with anorexia nervosa and comorbid Borderline personality disorder (AN+BPD) differ in characteristics related to admission to, discharge from, and course of specialized inpatient eating disorder treatment.
Journal ArticleDOI
[Treatment of obsessive-compulsive disorders: recommendations of the revised S3 guidelines on obsessive-compulsive disorders].
Ulrich Voderholzer,Matthias Favreau,Antonie Rubart,Angelica Staniloiu,Andreas Wahl-Kordon,Bartosz Zurowski,Norbert Kathmann +6 more
TL;DR: There were no major changes in the central basic therapy recommendations compared with the first version of the guidelines, as the evidence base has not fundamentally changed since then.